Charles River Laboratories International Inc (CRL)
233.47
+3.58
(+1.56%)
USD |
NYSE |
May 03, 16:00
233.40
-0.06
(-0.03%)
After-Hours: 20:00
Charles River Laboratories International Net Income (Quarterly): 187.08M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 187.08M |
| September 30, 2023 | 87.39M |
| June 30, 2023 | 97.02M |
| March 31, 2023 | 103.13M |
| December 31, 2022 | 187.41M |
| September 30, 2022 | 96.47M |
| June 30, 2022 | 109.32M |
| March 31, 2022 | 93.02M |
| December 31, 2021 | 137.58M |
| September 30, 2021 | 103.43M |
| June 30, 2021 | 88.45M |
| March 31, 2021 | 61.53M |
| December 31, 2020 | 143.19M |
| September 30, 2020 | 102.91M |
| June 30, 2020 | 67.44M |
| March 31, 2020 | 50.77M |
| December 31, 2019 | 80.35M |
| September 30, 2019 | 72.81M |
| June 30, 2019 | 43.73M |
| March 31, 2019 | 55.13M |
| December 31, 2018 | 59.66M |
| September 30, 2018 | 60.37M |
| June 30, 2018 | 53.71M |
| March 31, 2018 | 52.63M |
| December 31, 2017 | -29.85M |
| Date | Value |
|---|---|
| September 30, 2017 | 52.47M |
| June 30, 2017 | 53.95M |
| March 31, 2017 | 46.78M |
| December 31, 2016 | 44.68M |
| September 30, 2016 | 37.74M |
| June 30, 2016 | 35.21M |
| March 31, 2016 | 37.14M |
| December 31, 2015 | 31.88M |
| September 30, 2015 | 37.38M |
| June 30, 2015 | 48.51M |
| March 31, 2015 | 31.54M |
| December 31, 2014 | 27.17M |
| September 30, 2014 | 32.04M |
| June 30, 2014 | 35.26M |
| March 31, 2014 | 32.23M |
| December 31, 2013 | 19.10M |
| September 30, 2013 | 30.87M |
| June 30, 2013 | 27.28M |
| March 31, 2013 | 25.58M |
| December 31, 2012 | 18.42M |
| September 30, 2012 | 21.97M |
| June 30, 2012 | 30.47M |
| March 31, 2012 | 26.44M |
| December 31, 2011 | 27.12M |
| September 30, 2011 | 18.80M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
43.73M
Minimum
Jun 2019
187.41M
Maximum
Dec 2022
100.69M
Average
96.47M
Median
Sep 2022
Net Income (Quarterly) Benchmarks
| Cardinal Health Inc | 258.00M |
| Stryker Corp | 788.00M |
| DaVita Inc | 239.65M |
| IDEXX Laboratories Inc | 235.58M |
| Medpace Holdings Inc | 102.59M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.013B |
| Total Expenses (Quarterly) | 880.55M |
| EPS Diluted (Quarterly) | 3.64 |
| Enterprise Value | 14.42B |
| Gross Profit Margin (Quarterly) | 35.92% |
| Profit Margin (Quarterly) | 18.46% |
| Earnings Yield | 3.95% |
| Operating Earnings Yield | 5.14% |
| Normalized Earnings Yield | 3.953 |